Exelixis Inc (EXEL): aksiya narxi va yangiliklar

Belgilar Belgilar	Narxi	Oʻzgartirishlar	Dinamika (%)	Trend	Avvalgi yopilish narxi	Ochish	Yuqori	Past	Hajmi	Bozor kapitali
SIXB Materials SIXB Materials	SIXB +0,26%	1 104,23	+2,86	+0,26%	—	1 101,37	1 103,63	1 104,77	1 091,41	—	—
SIXC Communications SIXC Communications	SIXC -1,57%	603,73	-9,62	-1,57%	—	613,35	613,35	613,35	601,49	—	—
SIXE Energy SIXE Energy	SIXE -0,62%	1 191,39	-7,44	-0,62%	—	1 198,83	1 199,68	1 199,75	1 182,41	—	—
SIXI Industrials SIXI Industrials	SIXI -0,93%	1 739,66	-16,29	-0,93%	—	1 755,95	1 754,06	1 756,03	1 734,69	—	—
SIXM Financials SIXM Financials	SIXM -0,53%	635,15	-3,36	-0,53%	—	638,51	637,41	637,41	633,05	—	—
SIXR Staples SIXR Staples	SIXR -0,65%	838,07	-5,45	-0,65%	—	843,52	843,35	846,40	838,15	—	—
SIXRE Real estate SIXRE Real estate	SIXRE -0,15%	215,62	-0,33	-0,15%	—	215,95	215,95	216,84	215,25	—	—
SIXT Technology SIXT Technology	SIXT +2,80%	3 226,81	+87,90	+2,80%	—	3 138,91	3 189,30	3 229,80	3 174,76	—	—
SIXU Utilities SIXU Utilities	SIXU +0,04%	934,77	+0,40	+0,04%	—	934,37	934,72	938,26	927,50	—	—
SIXV Health care SIXV Health care	SIXV -1,49%	1 455,44	-21,99	-1,49%	—	1 477,43	1 474,12	1 474,12	1 451,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,81%	2 399,54	+19,35	+0,81%	—	2 380,19	2 389,34	2 403,04	2 380,47	—	—

EXEL:NASDAQ

Exelixis Inc

44,96 US$

-2,37%

(-1,09) 1K

24-apr, 14:52:05 (GMT-4) · USD

Barcha belgilar

YBB

MAKS

	Belgi	Narxi	Oʻzgartirishlar	Dinamika (%)

EXEL tikeri uchun statistika yaratilmoqda...

Ochish

46,29 US$

Yuqori

46,65 US$

Past

44,54 US$

Bozor kapitali

11,42 mlrd

Oʻrtacha hajm

2,45 mln

Hajmi

1,20 mln

P/E koeffitsiyenti

16,19

52 haftalik eng yuqori

49,40 US$

52 haftalik eng past

33,76 US$

Aksiya boʻyicha daromad

2,78 US$

Beta

0,42

Muomaladagi aksiyalar

254,01 mln

Xodimlar soni

1 ming

Aloqador aksiyalar

VRTX

Vertex Pharmaceuticals Inc

431,88 US$

-0,74%

REGN

Regeneron Pharmaceuticals

748,30 US$

-2,31%

AXSM

Axsome Therapeutics Inc

Yangiliklar

Internetdagi manbalardan

TipRanks

1 kun oldin

Exelixis and Merck Advance Key Phase 3 Kidney Cancer Trial, Setting Up a New Catalyst for EXEL

The Globe and Mail

1 kun oldin

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Exelixis (EXEL) and Community Health (CYH)

Investor's Business Daily

2 kun oldin

Why Dow Jones Stock Merck Skidded 4% — And Boosted A Key Rival

Profil

Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. Wikipedia

Exelixis Inc haqida

CEOMichael M. Morrissey

Xodimlar soni1,08 ming

Asos solingan15-noy, 1994

Bosh ofislarAlameda, Kaliforniya, Amerika Qo‘shma Shtatlari

Sektor-

Veb-saytexelixis.com

Barcha qiymatlar – USD	mar, 2025	iyn, 2025	sen, 2025	dek, 2025
Daromad	555,45 mln	568,26 mln	597,76 mln	598,66 mln
Sotilgan mahsulotning tannarxi	19,17 mln	19,47 mln	18,57 mln	26,48 mln
Daromad narxi	19,17 mln	19,47 mln	18,57 mln	26,48 mln
Tadqiqot va ishlanmalarga xarajatlar	212,23 mln	200,36 mln	199,16 mln	213,25 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar	-	-	-	-
Tijoriy, umumiy va maʼmuriy xarajatlar	137,18 mln	134,86 mln	123,66 mln	123,02 mln
Operatsion xarajatlar	349,42 mln	335,22 mln	322,82 mln	336,27 mln
Jami operatsion xarajatlar	368,59 mln	354,68 mln	341,40 mln	362,75 mln
Operatsion daromad	186,86 mln	213,58 mln	256,36 mln	235,91 mln
Boshqa nooperatsion daromad	-245,00 ming	50,00 ming	-49,00 ming	46,00 ming
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar	205,69 mln	230,42 mln	252,41 mln	252,69 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno	205,69 mln	230,42 mln	272,23 mln	253,38 mln
Daromad soligʻi boʻyicha xarajat	46,07 mln	45,57 mln	58,84 mln	8,16 mln
Amaldagi soliq stavkasi	22,40%	19,78%	23,31%	3,23%
Boshqa operatsion xarajatlar	-	-	-	-
Sof foyda	159,62 mln	184,85 mln	193,58 mln	244,53 mln
Sof foyda marjasi	28,74%	32,53%	32,38%	40,85%
Har bir aksiya foydasi	0,62	0,75	0,78	0,94
Foizlar va investitsiyalardan olingan daromadlar	19,08 mln	16,79 mln	15,92 mln	17,43 mln
Foizlarni toʻlash xarajatlari	-	-	-	-
Foizlarni toʻlash boʻyicha sof xarajatlar	19,08 mln	16,79 mln	15,92 mln	17,43 mln
Amortizatsiya ajratmalari	-	-	-	-
EBITDA	194,20 mln	220,92 mln	263,78 mln	242,86 mln
Aktivlarni sotishdan olingan foyda yoki zarar	-	-	-	-

AI kontentda xatolar boʻlishi mumkin. Batafsil

YordamFikr-mulohazaMaxfiylik Shartlar Majburiyatlardan voz kechish

Finance

Tahlil